Home » Newsletters » The Carlat Addiction Treatment Report

The Carlat Addiction Treatment Report

Stimulant Use Disorder (May/June) | 2021

View Archived Issues

Learning Objectives, Stimulant Use Disorder, CATR, May/June 2021

May 21, 2021

After reading these articles, you should be able to… Read More

Welcoming Our New Editor-in-Chief

May 21, 2021

We’re pleased to introduce Noah Capurso, MD, MHS as the new editor-in-chief of The Carlat Addiction Treatment Report. Dr. Capurso is an assistant professor of psychiatry at the Yale University School of Medicine and practices clinically at the West Haven Veterans Administration Hospital. Read More

Pharmacotherapy for Stimulant Use Disorders

May 21, 2021

Rehan Aziz, MD.

There are no approved pharmacotherapies for stimulant use disorders. Lots of medications have been studied and the results have been mixed. Here we provide you with the latest data, and some treatment recommendations. Read More

Diagnosing and Treating Stimulant Use Disorders

May 21, 2021

Adriane dela Cruz, MD, PhD

Dr. de la Cruz gives advice for working with patients with addiction to prescription and illicit stimulants. She provides concrete strategies for diagnosis, harm reduction, evidence-based treatments, and contingency management in this challenging patient population. Read More

An Unexpected Opioid: Loperamide Misuse

May 21, 2021

Mara Storto, MD. and Deepti Anbarasan, MD.

We normally think of loperamide as an over-the-counter drug with a good safety profile. And it is, but only when used as directed. Recreational misuse of loperamide is on the rise with some dangerous collateral effects. Read More

A Psychosocial Intervention for Chronic Pain and SUD

May 21, 2021

David A. Moltz, MD.

Does marijuana use reduce pain and improve quality of life over time? This observational, uncontrolled trial suggests it might, but also identifies the need for more rigorous future studies. Read More